Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.79 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.72 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 6/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.48 |
| ▸ | S1PR3 | Q99500 | 6/20 | 0.48 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.48 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8058830 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL3211535 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL767101 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL1981026 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL9701682 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL767546 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL630093 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL9702784 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL1636300 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 | |
| SCHEMBL767032 | 1.00 | TYMS (0.79) | TYMSLPAR3LPAR2LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0513760-A2 | Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol | E.R. SQUIBB & SONS, INC. (US) | 1992-11-19 | — | — | EP | claimed |
| EP-4018465-B1 | SUPERCAPACITORS COMPRISING PHOSPHONATE AND ARSONATE METAL ORGANIC FRAMEWORKS (MOFS) AS ACTIVE ELECTRODE MATERIALS | UNIV BERLIN TECH (DE) | 2025-12-17 | — | — | EP | disclosed |
| US-12170168-B2 | Supercapacitors comprising phosphonate and arsonate metal organic frameworks (MOFs) as active electrode materials | TECHNISCHE UNIVERSITAT BERLIN (DE) | 2024-12-17 | — | — | US | disclosed |
| US-20220293350-A1 | SUPERCAPACITORS COMPRISING PHOSPHONATE AND ARSONATE METAL ORGANIC FRAMEWORKS (MOFS) AS ACTIVE ELECTRODE MATERIALS | Technische Universität Berlin (DE) | 2022-09-15 | — | — | US | disclosed |
| EP-4018465-A1 | SUPERCAPACITORS COMPRISING PHOSPHONATE AND ARSONATE METAL ORGANIC FRAMEWORKS (MOFS) AS ACTIVE ELECTRODE MATERIALS | Technische Universität Berlin (DE) | 2022-06-29 | — | — | EP | disclosed |
| EP-1019454-B1 | COMPOSITE PIGMENT | CIBA SC HOLDING AG (CH) | 2001-11-07 | — | — | EP | disclosed |
| US-6203909-B1 | ORGANIC PIGMEMTS WITH SUBSTRATES | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-03-20 | — | — | US | disclosed |
| US-6030748-A | PHOTOSENSITIVE LAYER OF A HYDROLYZED AND POLYCONDENSED POLYMER OF ORGANOSILICONE OR ORGANOMETALLIC COMPOUND MONOMER IN A SOLVENT HAVING DISSOLVED THEREIN A PHENOL COMPOUND OR AN ORGANIC PHOSPHORIC ACID | FUJI PHOTO FILM CO., LTD. (JP) | 2000-02-29 | — | — | US | disclosed |
| EP-0513760-A2 | Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol | E.R. SQUIBB & SONS, INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| US-4210643-A | TREATING DIABETES MELLITUS WITH ETHANE-1-AMINO1,1-DIPHOSPHONIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1980-07-01 | — | — | US | disclosed |
| US-4113861-A | FOR TREATMENT OF DIABETES BY AFFECTING CARBOHYDRATE METABOLISM | THE PROCTER & GAMBLE COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4113862-A | FOR TREATMENT OF DIABETES BY AFFECTING CARBOHYDRATE METABOLISM | THE PROCTER & GAMBLE COMPANY (US) | 1978-09-12 | — | — | US | disclosed |